1. Home
  2. IQV vs HSY Comparison

IQV vs HSY Comparison

Compare IQV & HSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • HSY
  • Stock Information
  • Founded
  • IQV 1982
  • HSY 1894
  • Country
  • IQV United States
  • HSY United States
  • Employees
  • IQV N/A
  • HSY N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • HSY Specialty Foods
  • Sector
  • IQV Health Care
  • HSY Consumer Staples
  • Exchange
  • IQV Nasdaq
  • HSY Nasdaq
  • Market Cap
  • IQV 38.1B
  • HSY 34.6B
  • IPO Year
  • IQV 2013
  • HSY N/A
  • Fundamental
  • Price
  • IQV $192.62
  • HSY $170.90
  • Analyst Decision
  • IQV Buy
  • HSY Sell
  • Analyst Count
  • IQV 16
  • HSY 19
  • Target Price
  • IQV $259.40
  • HSY $187.06
  • AVG Volume (30 Days)
  • IQV 1.9M
  • HSY 1.9M
  • Earning Date
  • IQV 10-31-2024
  • HSY 11-07-2024
  • Dividend Yield
  • IQV N/A
  • HSY 3.21%
  • EPS Growth
  • IQV 27.98
  • HSY N/A
  • EPS
  • IQV 7.62
  • HSY 8.70
  • Revenue
  • IQV $15,315,000,000.00
  • HSY $10,971,834,000.00
  • Revenue This Year
  • IQV $3.68
  • HSY $1.79
  • Revenue Next Year
  • IQV $4.89
  • HSY $2.64
  • P/E Ratio
  • IQV $25.29
  • HSY $19.66
  • Revenue Growth
  • IQV 3.10
  • HSY N/A
  • 52 Week Low
  • IQV $189.63
  • HSY $170.58
  • 52 Week High
  • IQV $261.73
  • HSY $211.92
  • Technical
  • Relative Strength Index (RSI)
  • IQV 26.80
  • HSY 34.66
  • Support Level
  • IQV $216.74
  • HSY $171.67
  • Resistance Level
  • IQV $225.91
  • HSY $184.90
  • Average True Range (ATR)
  • IQV 7.63
  • HSY 4.38
  • MACD
  • IQV -1.28
  • HSY 0.16
  • Stochastic Oscillator
  • IQV 8.24
  • HSY 2.23

About IQV IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About HSY The Hershey Company

Hershey is a leading confectionery manufacturer in the us (around a $25 billion market), controlling around 36% of the domestic chocolate space (per Euromonitor). Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the us, including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix, Pirate Brands, and Dot's Pretzels over the past few years.

Share on Social Networks: